We are live on
!
Find out more
OP
Omni Partners Portfolio holdings
AUM
$2.03B
1-Year Est. Return
126.33%
This Fund
S&P 500
This Quarter
Est. Return
+15.53%
1 Year Est. Return
+126.33%
3 Year Est. Return
+411.65%
5 Year Est. Return
+1,549.93%
10 Year Est. Return
–
AUM
$3.73B
AUM Growth
+$2.35B
(+171%)
Cap. Flow
-$91.1M
Cap. Flow
% of AUM
-2.44%
Top 10 Holdings %
Top 10 Hldgs %
92.1%
Holding
54
New
24
Increased
5
Reduced
5
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$154M |
| 2 |
TGE
Tallgrass Energy, LP Class A Shares
TGE
|
+$89.1M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$43.3M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$37.1M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
+$35.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$243M |
| 2 |
CY
Cypress Semiconductor
CY
|
+$108M |
| 3 |
VSM
Versum Materials, Inc.
VSM
|
+$99.7M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$45.8M |
| 5 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.21% |
| 2 | Miscellaneous | 28.54% |
| 3 | Healthcare | 18.71% |
| 4 | Consumer Discretionary | 4.6% |
| 5 | Communication Services | 4.57% |
Similar funds
BUB
PAG
SBSB
PPCM
AAM
ALSV
TNB
FIB
Omni Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Omni Partners held 54 positions worth $3.73B, up 171% from $1.38B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Omni Partners's Q4 2019 filing shows 24 new, 5 increased, 5 reduced and 12 closed positions. Its largest new stake was Medicines Co: 2,311,536 shares worth $196M. The largest sale was Celgene Corp, an estimated $243M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Healthcare.
- Omni Partners's largest Q4 2019 buy was Medicines Co: 2,311,536 shares worth $196M.
- Omni Partners added most to Wellcare Health Plans, Inc. in Q4 2019, an estimated $43.3M increase.
- Omni Partners's biggest Q4 2019 reduction was Cypress Semiconductor, cutting an estimated $108M.
- Omni Partners fully exited Celgene Corp in Q4 2019, selling an estimated $243M.
- Omni Partners's ten largest holdings make up 92% of its $3.73B portfolio in Q4 2019.
- Omni Partners opened 24 new positions and closed 12 in Q4 2019.
- Omni Partners's portfolio value rose 171% quarter-over-quarter to $3.73B.
Based on Omni Partners's 13F filing for Q4 2019, filed 13 Feb 2020.